✦ LIBER ✦

Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I

✍ Scribed by Revecca Kakavanos; Chris T Turner; John J Hopwood; Emil D Kakkis; Doug A Brooks

Book ID: 117283633
Publisher: The Lancet
Year: 2003
Tongue: English
Weight: 269 KB
Volume: 361
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(03)13311-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enzyme Replacement Therapy in Patients W

Enzyme Replacement Therapy in Patients Who Have Mucopolysaccharidosis I and Are Younger Than 5 Years: Results of a Multinational Study of Recombinant Human -L-Iduronidase (Laronidase)

✍ Wraith, J. Edmond (author);Beck, Michael (author);Lane, Roderick (author);Van De 📂 Article 📅 2007 🏛 American Academy of Pediatrics 🌐 English ⚖ 408 KB

Enzyme Replacement Therapy in Patients W

Enzyme Replacement Therapy in Patients Who Have Mucopolysaccharidosis I and Are Younger Than 5 Years: Results of a Multinational Study of Recombinant Human -L-Iduronidase (Laronidase)

✍ Wraith, J. Edmond (author);Beck, Michael (author);Lane, Roderick (author);Van De 📂 Article 📅 2007 🏛 American Academy of Pediatrics 🌐 English ⚖ 408 KB

Enzyme replacement therapy for mucopolys

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant humanN-acetylgalactosamine 4-sulfatase

✍ Paul Harmatz; Zi-Fan Yu; Roberto Giugliani; Ida Vanessa D. Schwartz; Nathalie Gu 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 239 KB